Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bushen Jieyu Tiaochong Formula (BJTF) is a traditional Chinese medicine prescription used primarily for the treatment of polycystic ovary syndrome (PCOS). It functions by reducing apoptosis of granulosa cells through modulation of the PERK-ATF4-CHOP signaling pathway, which is involved in cellular stress responses. BJTF has been shown in animal models to normalize hormone levels, reduce cystic follicle dilation, and alleviate psychological stress-related behavioral changes associated with PCOS. The formula aims to restore balance between kidney function, Tiangui (a concept related to female reproductive hormones), Chongren meridians, and uterus function according to traditional Chinese medicine principles. BJTF also demonstrates potential cardiovascular protective effects by lowering risks associated with coronary heart disease in PCOS patients. Its mechanism involves endocrine regulation and neuroendocrine modulation relevant to female reproduction[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bushen Jieyu Tiaochong Formula.